Benefit risk assessment and update on the use of docetaxel in the management of breast cancer
Scheryll Alken, Catherine M KellyDepartment of Medical Oncology, Mater Misericordiae University Hospital, Dublin, IrelandAbstract: The objective of this paper is to review the data supporting the use of docetaxel in the treatment of breast cancer, focusing on pharmacokinetics, efficacy in adjuvant a...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-10-01
|
Series: | Cancer Management and Research |
Online Access: | http://www.dovepress.com/benefit-risk-assessment-and-update-on-the-use-of-docetaxel-in-the-mana-a14686 |